Lexicon Pharmaceuticals Launches $95 Million Common Share Offering

March 9, 2010 (FinancialWire) Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is offering to sell $95 MILLION of its common stock in an underwritten public offering. Morgan Stanley (NYSE: MS) and J.P. Morgan Securities (NYSE: JPM) will be acting as joint book-runners.…

Source: EIN